(October 19, 2026) Ossiform® is pleased to announce that CEO, Thea Wulff Olesen and U.S. Commercial Lead, Mark Singer will attend the 2026 Musculoskeletal New Ventures Conference (MNVC) in Memphis, Tennessee, on October 27-28. Thea Wulff Olesen has been invited to present Ossiform® and our vision for the future of orthopedic repair.

For decades, orthopedic repair has relied on permanent metal implants. While these devices play an important role in patient care today, they can also leave patients with long-term implant-related complications and the need for revision procedures years after surgery.

Ossiform® was founded to help change that.

Our proprietary 3D printing technology platform enables the production of structural, bioactive bone substitutes from bone-like materials. Our vision is to replace permanent foreign bodies with solutions that support healing, integrate with the body, and ultimately are replaced by the patient’s own anatomy.

As Ossiform® continues to expand its presence in the U.S., Thea Wulff Olesen and Mark singer are looking forward to meeting investors, clinicians, and strategic partners who share our vision of transforming orthopedic repair by replacing permanent implants with regenerative solutions.

MNVC brings together leading clinicians, investors, researchers, entrepreneurs, and industry executives from across the musculoskeletal sector, creating an ideal forum to discuss the next generation of orthopedic technologies.

Join us in ending the era of permanent foreign bodies in bone repair.

We believe the future of orthopedic repair lies not in permanent foreign bodies, but in solutions that work with the body’s natural ability to heal.

Book a meeting with Group CEO, Thea Wulff Olesen:
Email: [email protected]
Mobile: +45 26 32 63 32